BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3690140)

  • 1. Plasma oxipurinol concentrations during allopurinol therapy.
    Emmerson BT; Gordon RB; Cross M; Thomson DB
    Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
    Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
    Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
    Wung WE; Howell SB
    Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.
    Turnheim K; Krivanek P; Oberbauer R
    Br J Clin Pharmacol; 1999 Oct; 48(4):501-9. PubMed ID: 10583019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
    Yamanaka H; Nishioka K; Suzuki T; Kohno K
    Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
    Day RO; Miners J; Birkett DJ; Graham GG; Whitehead A
    Br J Clin Pharmacol; 1988 Oct; 26(4):429-34. PubMed ID: 3190993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
    Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
    J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
    Drugs R D; 2004; 5(3):171-5. PubMed ID: 15139781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
    Hosoya T; Ichida K; Tabe A; Sakai O
    Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of serum oxipurinol concentration and renal function in patients administered allopurinol].
    Saji M
    Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):640-50. PubMed ID: 9014485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of allopurinol and oxipurinol in biological fluids by mass fragmentography.
    Lartigue-Mattei C; Chabard JL; Bargnoux H; Petit J; Berger JA
    J Chromatogr; 1982 Apr; 229(1):211-6. PubMed ID: 7085828
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
    Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
    Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
    Mertz DP; Eichhorn R
    Klin Wochenschr; 1984 Dec; 62(24):1170-2. PubMed ID: 6530890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of allopurinol in long-term treatments for optimal effect].
    Fenner H
    Fortschr Med; 1980 Mar; 98(10):(373-6). PubMed ID: 7372221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy.
    Peterson GM; Boyle RR; Francis HW; Oliver NW; Paterson J; von Witt RJ; Taylor GR
    Eur J Clin Pharmacol; 1990; 39(4):419-21. PubMed ID: 2076730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
    Reinders MK; Nijdam LC; van Roon EN; Movig KL; Jansen TL; van de Laar MA; Brouwers JR
    J Pharm Biomed Anal; 2007 Oct; 45(2):312-7. PubMed ID: 17890037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.